REGN

REGENERON PHARMACEUTICALS INC

Healthcare | Large Cap

$10.55

EPS Forecast

$3,872

Revenue Forecast

Announcing earnings for the quarter ending 2024-12-31 soon

Proximilar's AI forecasts

EPS Forecast:

$10.55

Revenue Forecast:

$3,872

EPS Surprise Forecast:

$0.772

Revenue Surprise Forecast:

$56

Post-release price volatility - Medium

Post-release Overnight Move:

±5.6%

Post-release 1-week Move:

Odds of beating consensus

Probability of beating EPS consensus:

Probability of beating revenue consensus:

Probability of beating both EPS & revs consensus:

Probability of missing both EPS & revs consensus:

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

Beta (β)

Forward Looking Beta (β):

Earnings volatility

EPS standard deviation:

Revenue standard deviation:

Confidence intervals and percentiles

EPS 95th %ile:

Revenue 95th %ile:

$4,086

EPS 75th %ile:

$11.08

Revenue 75th %ile:

EPS 25th %ile:

$10.22

Revenue 25th %ile:

EPS 5th %ile:

Revenue 5th %ile:

$3,703

Stock's bid-ask spread

Bid-ask per $10K:

Bid-ask per Share: